Stroke ranks as the fourth leading cause of death in the U.S. and remains a significant contributor to adult disability, with 800,000 cases reported annually.
Hyperbaric oxygen therapy (HBOT) has demonstrated efficacy in both stroke prevention and treatment through various mechanisms.
HBOT can precondition the brain by stimulating angiogenesis, thereby creating additional circulatory pathways throughout the brain and potentially reducing the risk of stroke.
Additionally, this has proven beneficial for post-stroke patients, as heightened oxygen levels can aid in the recovery of compromised blood flow to the affected brain tissue (penumbra) and its functionality.
Research has showcased the following therapeutic advantages of HBOT for patients in stroke recovery, with potential preventive benefits for strokes.
The information provided on this website is for educational purposes only and should not be viewed as a substitute for the diagnosis, treatment, or advice of a qualified licensed professional. This website offers general information and does not represent the practice of medicine. We do not take responsibility for how this information is utilized. Additionally, please note that the contents of this website are regularly updated for various reasons. Any statements or implied treatments have not been evaluated or approved by the FDA. It is crucial not to alter, discontinue, or change any medication or treatment without consulting your doctor first. Always seek your doctor’s advice before initiating any new treatment program.
The following research article underscores how hyperbaric oxygen therapy aided patients in stroke recovery..
If you have inquiries regarding a particular symptom or condition, please don't hesitate to reach out to us for assistance!
In January 2013, a prospective, randomized, controlled trial examined the effects of introducing hyperbaric oxygen therapy (HBOT) to post-stroke patients. A total of 59 participants, who had experienced a stroke 6 to 36 months prior and exhibited at least one motor dysfunction, were randomly divided into treated and cross-over groups. The treated group received two months of 40 one-hour HBOT sessions, while the cross-over group underwent evaluation after one month without HBOT and again after one month following HBOT, following the same treatment protocol. Physicians noted improved neurological function, brain activity, and quality of life in all treated patients after HBOT. SPECT imaging results, corroborating clinical improvements, suggested that HBOT could significantly enhance neurological outcomes in post-stroke patients, even during chronic stages. These findings indicated the potential activation of neuroplasticity long after the onset of damage.
Learn about purchase and rental programs.
Copyright © 2024 Hyperbaric Hub LLC All Rights Reserved